No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading
Express News | Ascendis Pharma A/S : RBC Initiates Coverage With Outperform Rating; Price Target $205
Ascendis Pharma (ASND) Receives a Buy From Evercore ISI
BofA Securities Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $192
There's Reason For Concern Over Ascendis Pharma A/S' (NASDAQ:ASND) Price
Ascendis Pharma Files New Drug Application for Achondroplasia Medication